|
|
Article: Control of late-phase allergic conjunctivitis response possible
- Article from:
- Ophthalmology Times
- Article date:
- May 15, 2004
- Author:
CopyrightCopyright Advanstar Communications, Inc. May 15, 2004. Provided by ProQuest LLC. (Hide copyright information)
|
Treatment option
Positive effect seen with azelastine solution in early, late phases of allergic response
About 45% of the U.S. population suffers from ocular allergies. Of this, about 20% have seasonal or perennial ocular allergies, also known as allergic conjunctivitis. These numbers translate to a local level; roughly 70% of my patients here in Florida who present with red eyes have them due to allergies.
When patients present with the hallmark ocular allergy symptoms-itching, watery discharge, and white, stringy mucus-they are probably seeking a prescription treatment that will provide the fast-acting relief they were not able to get with over-the-counter (OTC) medications.
While ...